Two Sigma Advisers’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-22,809
| Closed | -$200K | – | 766 |
|
|
2025
Q4 | $200K | Buy |
+22,809
| New | +$223K | ﹤0.01% | 2127 |
|
|
2025
Q2 | – | Sell |
-27,048
| Closed | -$210K | – | 2391 |
|
|
2025
Q1 | $210K | Sell |
27,048
-8,088
| -23% | -$97K | ﹤0.01% | 2121 |
|
|
2024
Q4 | $465K | Buy |
35,136
+5,424
| +18% | +$50.4K | ﹤0.01% | 1803 |
|
|
2024
Q3 | $297K | Sell |
29,712
-17,792
| -37% | -$268K | ﹤0.01% | 1912 |
|
|
2024
Q2 | $1.06M | Sell |
47,504
-668
| -1% | -$20.6K | ﹤0.01% | 1523 |
|
|
2024
Q1 | $2.83M | Sell |
48,172
-23,844
| -33% | -$1.03M | 0.01% | 1042 |
|
|
2023
Q4 | $1.6M | Buy |
72,016
+6,708
| +10% | +$101K | ﹤0.01% | 1409 |
|
|
2023
Q3 | $1.41M | Buy |
65,308
+33,804
| +107% | +$1.33M | ﹤0.01% | 1378 |
|
|
2023
Q2 | $2.13M | Sell |
31,504
-176
| -0.6% | -$72.8K | 0.01% | 1167 |
|
|
2023
Q1 | $14.8M | Buy |
31,680
+5,748
| +22% | +$3.04M | 0.04% | 417 |
|
|
2022
Q4 | $10.4M | Buy |
25,932
+496
| +2% | +$190K | 0.03% | 500 |
|
|
2022
Q3 | $8.27M | Sell |
25,436
-1,880
| -7% | -$605K | 0.02% | 545 |
|
|
2022
Q2 | $7.21M | Sell |
27,316
-5,356
| -16% | -$1.37M | 0.02% | 618 |
|
|
2022
Q1 | $9.82M | Sell |
32,672
-2,848
| -8% | -$993K | 0.03% | 531 |
|
|
2021
Q4 | $12.5M | Sell |
35,520
-4,856
| -12% | -$1.51M | 0.03% | 436 |
|
|
2021
Q3 | $10.3M | Buy |
40,376
+25,632
| +174% | +$9.08M | 0.03% | 511 |
|
|
2021
Q2 | $9.82M | Buy |
14,744
+7,712
| +110% | +$4.44M | 0.03% | 573 |
|
|
2021
Q1 | $6.1M | Buy |
7,032
+1,580
| +29% | +$1.68M | 0.02% | 767 |
|
|
2020
Q4 | $5.05M | Sell |
5,452
-1,744
| -24% | -$1.83M | 0.01% | 807 |
|
|
2020
Q3 | $7.4M | Sell |
7,196
-2,332
| -24% | -$2.51M | 0.02% | 621 |
|
|
2020
Q2 | $9.65M | Buy |
9,528
+3,368
| +55% | +$3.13M | 0.03% | 568 |
|
|
2020
Q1 | $5.35M | Sell |
6,160
-1,312
| -18% | -$1.3M | 0.02% | 687 |
|
|
2019
Q4 | $8.01M | Buy |
7,472
+256
| +4% | +$261K | 0.02% | 664 |
|
|
2019
Q3 | $6.67M | Buy |
7,216
+568
| +9% | +$624K | 0.02% | 672 |
|
|
2019
Q2 | $7.51M | Buy |
6,648
+3,484
| +110% | +$3.81M | 0.02% | 682 |
|
|
2019
Q1 | $4.3M | Sell |
3,164
-60
| -2% | -$81.4K | 0.01% | 892 |
|
|
2018
Q4 | $3.73M | Buy |
3,224
+1,128
| +54% | +$1.27M | 0.01% | 908 |
|
|
2018
Q3 | $3.18M | Sell |
2,096
-156
| -7% | -$240K | 0.01% | 1011 |
|
|
2018
Q2 | $3.52M | Sell |
2,252
-632
| -22% | -$824K | 0.01% | 1023 |
|
|
2018
Q1 | $3.33M | Buy |
2,884
+1,072
| +59% | +$1.41M | 0.01% | 1015 |
|
|
2017
Q4 | $2.15M | Buy |
1,812
+428
| +31% | +$537K | 0.01% | 1210 |
|
|
2017
Q3 | $1.86M | Buy |
1,384
+172
| +14% | +$181K | 0.01% | 1250 |
|
|
2017
Q2 | $979K | Buy |
1,212
+744
| +159% | +$518K | ﹤0.01% | 1527 |
|
|
2017
Q1 | $288K | Sell |
468
-272
| -37% | -$166K | ﹤0.01% | 2100 |
|
|
2016
Q4 | $396K | Buy |
+740
| New | +$369K | ﹤0.01% | 1978 |
|
|
2016
Q1 | – | Sell |
-524
| Closed | -$399K | – | 2063 |
|
|
2015
Q4 | $399K | Buy |
+524
| New | +$348K | ﹤0.01% | 1408 |
|
Other funds holding KYNB
AC
Two Sigma Advisers's KYNB Position: Q1 2026 in Review
Two Sigma Advisers sold out of Kyntra Bio (KYNB) in Q1 2026, closing a stake of 22,809 shares — an estimated $200K sold.
Two Sigma Advisers first reported a position in KYNB in Q4 2015 and held it in 36 quarters. The position peaked at $14.8M in Q1 2023. 32 funds tracked by Wall St. Rank hold KYNB as of Q1 2026.
- Two Sigma Advisers reported no remaining Kyntra Bio position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 22,809 Kyntra Bio shares in Q1 2026, an estimated $200K.
- Two Sigma Advisers first reported a position in Kyntra Bio in Q4 2015 and held it in 36 quarters.
- Two Sigma Advisers's Kyntra Bio position peaked at $14.8M in Q1 2023.
- 32 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.